Securing the advancement of clinical research in the field of infectious diseases   Utrecht, Wednesday February 24th – Following the signing of the Grant Agreement by the European Commission (EC), ECRAID-Base has secured funding of 30 million euros and will commence March 1st 2021. ECRAID-Base is the core set of activities for ECRAID (the European Clinic... read more

In the past seven years, many ground-breaking research studies, data analyses, reviews, and surveys have been performed under PREPARE’s umbrella. To celebrate the end of the project and showcase its many achievements and milestones to the outside world, PREPARE is launching a series of five webinars that will be held every Wednesday at 14:00 CET from 17 March to... read more

The Adaptive Platform Trial for Community-Acquired Pneumonia, REMAP-CAP, launched its second video. The video shows the smart, efficient and optimized design of REMAP-CAP.  As an adaptive platform, REMAP-CAP is designed to adapt in the event of a pandemic, increasing the likelihood of patients receiving an effective treatment. Since the COVID-19 outbreak, the ... read more

Critically ill patients with COVID-19 treated with a drug that reduces inflammation by modifying the immune system require shorter durations of organ support in the intensive care unit, an international study has found. The early findings, which are yet to be published, come from the REMAP-CAP trial, sponsored by the UMC Utrecht in Europe and led by Imperial College ... read more

REMAP-CAP, an Adaptive Platform Trial for Community-Acquired Pneumonia, launched its first in a series of videos. The video shows the uniqueness, smart, and easy-to-handle design of this trial. As an adaptive platform, REMAP-CAP is designed to adapt in the event of a pandemic, increasing the likelihood of patients receiving an effective treatment. Combatting antimi... read more

Across the EU, many people are worried about the novel coronavirus and its rapid spread. The EU project PREPARE, which began in 2014, is responding to COVID-19 by rapidly assessing Europe’s preparedness and deploying vital clinical research.   Read the full article on the European Commission website.

Antwerp, Belgium – 11 March, 2020 The University of Antwerp has launched Rapid European COVID-19 Emergency Research response (RECOVER), in collaboration with 9 international partners. The launch comes in response to the impact of the novel Coronavirus (COVID-19) epidemic in Europe. This project was selected for funding by the European Union under the Horizon ... read more

Antwerp, Belgium – 3 March 2020 The EU-funded Platform foR European Preparedness Against (Re-) emerging Epidemics (PREPARE) has decided to upgrade its response efforts to the novel Coronavirus (SARS-CoV-2) epidemic to Outbreak Research Response Mode 3, the highest response mode. This means that PREPARE will immediately initiate and implement clinical research s... read more

Antwerp, Belgium – 24 February 2020 Confirmed SARS-CoV-2 infected patients have been reported in Europe for several weeks now and PREPARE has been monitoring developments very closely. In Italy, cases of the novel coronavirus, SARS-CoV-2, have risen significantly over the weekend. Italian public health authorities have pressed ahead with measures to contain t... read more

Antwerp, Belgium – 6 February 2020 On 30th January 2020, the Director General of the World Health Organisation (WHO) declared the outbreak of 2019-nCoV a public health emergency of international concern. In his statement, Dr Tedros Ghebreyesus called for solidarity and cooperation to accelerate preparations and to advance knowledge on the virus and its impact... read more